Christopher S. Holland

A sale of EUR 10,985,181 on November 2, 2017 at C. R. Bard Inc dominates the record of Christopher S. Holland. It is more than half of the EUR 19.3 million that the 16 sales add up to, which have a median of EUR 354,365. The next largest are EUR 1,980,899 at Jabil Inc on October 2, 2023 and EUR 1,702,186 at C. R. Bard Inc on February 9, 2017.

Christopher S. Holland filed 53 reports for three issuers: C. R. Bard Inc (36, as Senior Vice President and CFO), Jabil Inc (14, as a director) and STERIS plc (3, as a director). There is no purchase, but there are 27 grants, 4 option exercises and 6 other filings.

The curve is clear: 17 filings in 2016, 13 in 2017, 8 in 2018, then 1 to 3 a year through 2026. Two filings fall in the last twelve months, neither a sale. Publication comes a median of 3 days after the trade.

9, 8 and 8 trades by Holland fall within 30 days of colleagues at Bard C R Inc /NJ/, in that order. All of them in the same direction. The colleagues, in the same order: Timothy M. Ring, Jim C. Beasley and Sharon M. Luboff.